Clinical Trial Update: N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating N-Acetylcysteine to prevent renal injury after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Heart Disease, Acute Renal Failure | Phase 3 | Status: COMPLETED